This site is intended for US healthcare professionals only.
VISTOGARD® is indicated for the emergency treatment of adult and pediatric patients:
Limitations of use
Red flags developing early (especially during the first or second treatment cycle and appearing within 96 hours of 5-FU or capecitabine administration) should be addressed promptly. 1-3